Skip to main content
Download PDF
  • Research Article
  • Open access
  • Published:

KCa3.1 Inhibition Decreases Size and Alters Composition of Atherosclerotic Lesions Induced by Low, Oscillatory Flow

Artery Research volume 27, pages 93–100 (2021)Cite this article

Abstract

Low, oscillatory flow/shear patterns are associated with atherosclerotic lesion development. Increased expression of KCa3.1 has been found in Vascular Smooth Muscle (VSM), macrophages and T-cells in lesions from humans and mice. Increased expression of KCa3.1, is also required for VSM cell proliferation and migration. Previously, we showed that the specific KCa3.1 inhibitor, TRAM-34, could inhibit coronary neointimal development following balloon injury in swine. Atherosclerosis develops in regions with a low, oscillatory (i.e. atheroprone) flow pattern. Therefore, we used the Partial Carotid Ligation (PCL) model in high-fat fed, Apoe-/- mice to determine the role of KCa3.1 in atherosclerotic lesion composition and development. PCL was performed on 8–10 week old male Apoe-/- mice and subsequently placed on a Western diet (TD.88137, Teklad) for 4 weeks. Mice received daily s.c. injections of TRAM-34 (120 mg/kg) or equal volumes of vehicle (peanut oil, PO). 1-[(2-chlorophenyl) diphenylmethyl]-1H-pyrazole (TRAM-34) treatment reduced lesion size ~50% (p < 0.05). In addition, lesions from TRAM-34 treated mice contained less collagen (6% ± 1% vs. 15% ± 2%; p < 0.05), fibronectin (14% ± 3% vs. 32% ± 3%; p < 0.05) and smooth muscle content (19% ± 2% vs. 29% ± 3%; p < 0.05). Conversely, TRAM-34 had no effect on total cholesterol (1455 vs. 1334 mg/dl, PO and TRAM, resp.) or body weight (29.1 vs. 28.8 g, PO and TRAM, resp.). Medial smooth muscle of atherosclerotic carotids showed diminished RE1-Silencing Transcription Factor (REST)/Neural Restrictive Silencing Factor (NRSF) expression, while REST overexpression in vitro inhibited smooth muscle migration. Together, these data support a downregulation of REST/NRSF and upregulation of KCa3.1 in determining smooth muscle and matrix content of atherosclerotic lesions.

References

  1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 2015;131:e29–e322.

    Google Scholar 

  2. Silvestre-Roig C, de Winther MP, Weber C, Daemen MJ, Lutgens E, Soehnlein O. Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Circ Res 2014;114:214–26.

    Google Scholar 

  3. Ghanshani S, Wulff H, Miller MJ, Rohm H, Neben A, Gutman GA, et al. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 2000;275:37137–49.

    Google Scholar 

  4. Tharp DL, Wamhoff BR, Wulff H, Raman G, Cheong A, Bowles DK. Local delivery of the KCa3.1 blocker, TRAM-34, prevents acute angioplasty-induced coronary smooth muscle phenotypic modulation and limits stenosis. Arterioscler Thromb Vasc Biol 2008;28:1084–9.

    Google Scholar 

  5. Bi D, Toyama K, Lemaître V, Takai J, Fan F, Jenkins DP, et al. The intermediate conductance calcium-activated potassium channel KCa3.1 regulates vascular smooth muscle cell proliferation via controlling calcium-dependent signaling. J Biol Chem 2013;288: 15843–53.

    Google Scholar 

  6. Toyama K, Wulff H, Chandy KG, Azam P, Raman G, Saito T, et al. The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans. J Clin Invest 2008;118:3025–37.

    Google Scholar 

  7. Tharp DL, Wamhoff BR, Turk JR, Bowles DK. Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle. Am J Physiol Heart Circ Physiol 2006;291:H2493–H503.

    Google Scholar 

  8. Neylon CB, Lang RJ, Fu Y, Bobik A, Reinhart PH. Molecular cloning and characterization of the intermediate-conductance Ca2+-activated K+ channel in vascular smooth muscle: relationship between KCa channel diversity and smooth muscle cell function. Circ Res 1999;85:e33–e43.

  9. Köhler R, Wulff H, Eichler I, Kneifel M, Neumann D, Knorr A, et al. Blockade of the intermediate-conductance calcium-activated potassium channel as a new therapeutic strategy for restenosis. Circulation 2003;108:1119–25.

    Google Scholar 

  10. Suo J, Ferrara DE, Sorescu D, Guldberg RE, Taylor WR, Giddens DP. Hemodynamic shear stresses in mouse aortas: implications for atherogenesis. Arterioscler Thromb Vasc Biol 2007;27:346–51.

    Google Scholar 

  11. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis 1985;5:293–302.

    Google Scholar 

  12. Korshunov VA, Berk BC. Flow-induced vascular remodeling in the mouse: a model for carotid intima-media thickening. Arterioscler Thromb Vasc Biol 2003;23:2185–91.

    Google Scholar 

  13. Nam D, Ni CW, Rezvan A, Suo J, Budzyn K, Llanos A, et al. Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. Am J Physiol Heart Circ Physiol 2009;297:H1535–H43.

    Google Scholar 

  14. Smolock EM, Korshunov VA, Glazko G, Qiu X, Gerloff J, Berk BC. Ribosomal protein L17, RpL17, is an inhibitor of vascular smooth muscle growth and carotid intima formation. Circulation 2012;126:2418–27.

    Google Scholar 

  15. Korshunov VA, Berk BC. Strain-dependent vascular remodeling: the “Glagov phenomenon” is genetically determined. Circulation 2004;110:220–6.

    Google Scholar 

  16. Akhtar S, Gremse F, Kiessling F, Weber C, Schober A. CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice. Arterioscler Thromb Vasc Biol 2013;33:679–86.

    Google Scholar 

  17. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371–5.

    Google Scholar 

  18. Korshunov VA, Schwartz SM, Berk BC. Vascular remodeling: hemodynamic and biochemical mechanisms underlying Glagov’s phenomenon. Arterioscler Thromb Vasc Biol 2007; 27:1722–8.

  19. Nam D, Ni CW, Rezvan A, Suo J, Budzyn K, Llanos A, et al. A model of disturbed flow-induced atherosclerosis in mouse carotid artery by partial ligation and a simple method of RNA isolation from carotid endothelium. J Vis Exp 2010:1861.

  20. Thomas JA, Deaton RA, Hastings NE, Shang Y, Moehle CW, Eriksson U, et al. PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patterns. Am J Physiol Heart Circ Physiol 2009;296:H442–H52.

    Google Scholar 

  21. Gole HKA, Tharp DL, Bowles DK. Upregulation of intermediate-conductance Ca2+-activated K+ channels (KCNN4) in porcine coronary smooth muscle requires NADPH oxidase 5 (NOX5). PLoS One 2014;9:e105337.

  22. Long X, Tharp DL, Georger MA, Slivano OJ, Lee MY, Wamhoff BR, et al. The smooth muscle cell-restricted KCNMB1 ion channel subunit is a direct transcriptional target of serum response factor and myocardin. J Biol Chem 2009;284:33671–82.

    Google Scholar 

  23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2–ΔΔCT method. Methods 2001;25:402–8.

    Google Scholar 

  24. Wood IC, Belyaev ND, Bruce AW, Jones C, Mistry M, Roopra A, et al. Interaction of the repressor element 1-silencing transcription factor (REST) with target genes. J Mol Biol 2003;334:863–74.

    Google Scholar 

  25. Fleenor BS, Bowles DK. Negligible contribution of coronary adventitial fibroblasts to neointimal formation following balloon angioplasty in swine. Am J Physiol Heart Circ Physiol 2009;296:H1532–H9.

    Google Scholar 

  26. Atkinson C, Horsley J, Rhind-Tutt S, Charman S, Phillpotts CJ, Wallwork J, et al. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin. J Heart Lung Transplant 2004;23:427–35.

    Google Scholar 

  27. Bentzon JF, Majesky MW. Lineage tracking of origin and fate of smooth muscle cells in atherosclerosis. Cardiovasc Res 2018;114:492–500.

    Google Scholar 

  28. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005;111:3481–8.

    Google Scholar 

  29. Hibi K, Ward MR, Honda Y, Suzuki T, Jeremias A, Okura H, et al. Impact of different definitions on the interpretation of coronary remodeling determined by intravascular ultrasound. Catheter Cardiovasc Interv 2005;65:233–9.

    Google Scholar 

  30. Palumbo R, Gaetano C, Antonini A, Pompilio G, Bracco E, Rönnstrand L, et al. Different effects of high and low shear stress on platelet-derived growth factor isoform release by endothelial cells: consequences for smooth muscle cell migration. Arterioscler Thromb Vasc Biol 2002;22:405–11.

    Google Scholar 

  31. Ziegler T, Bouzourène K, Harrison VJ, Brunner HR, Hayoz D. Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells. Arterioscler Thromb Vasc Biol 1998;18:686–92.

    Google Scholar 

  32. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 2007;49:2379–93.

    Google Scholar 

  33. Xu R, Li C, Wu Y, Shen L, Ma J, Qian J, et al. Role of KCa3.1 channels in macrophage polarization and its relevance in atherosclerotic plaque instability. Arterioscler Thromb Vasc Biol 2017;37:226–36.

    Google Scholar 

  34. Grgic I, Kiss E, Kaistha BP, Busch C, Kloss M, Sautter J, et al. Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels. Proc Natl Acad Sci U S A 2009;106:14518–23.

    Google Scholar 

  35. Anumanthan G, Gupta S, Fink MK, Hesemann NP, Bowles DK, McDaniel LM, et al. KCa3.1 ion channel: a novel therapeutic target for corneal fibrosis. PLoS One 2018;13:e0192145.

  36. Tharp DL, Bowles DK. The intermediate-conductance Ca2+-activated K+ channel (KCa3.1) in vascular disease. Cardiovasc Hematol Agents Med Chem 2009;7:1–11.

    Google Scholar 

  37. Huang C, Shen S, Ma Q, Gill A, Pollock CA, Chen XM. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis. Nephrol Dial Transplant 2014;29:313–24.

    Google Scholar 

  38. Stouffer GA, Pathak A, Rojas M. Unilateral renal artery stenosis causes a chronic vascular inflammatory response in ApoE–/– mice. Trans Am Clin Climatol Assoc 2010;121:252–64; 264–6.

    Google Scholar 

  39. Kojima T, Murai K, Naruse Y, Takahashi N, Mori N. Cell-type non-selective transcription of mouse and human genes encoding neural-restrictive silencer factor. Mol Brain Res 2001;90:174–86.

    Google Scholar 

  40. Cheong A, Bingham AJ, Li J, Kumar B, Sukumar P, Munsch C, et al. Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation. Mol Cell 2005;20:45–52.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Sciences, E102 Veterinary Medicine, University of Missouri, 65211, Columbia, MO, USA

    Darla L. Tharp & Douglas K. Bowles

  2. Dalton Cardiovascular Research Center, University of Missouri, 65211, Columbia, MO, USA

    Douglas K. Bowles

Authors
  1. Darla L. Tharp
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Douglas K. Bowles
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Douglas K. Bowles.

Additional information

Peer review under responsibility of the Association for Research into Arterial Structure and Physiology

Data availability statement: The data that support the findings of this study are available from the corresponding author [DKB], upon reasonable request.

Rights and permissions

This is an open access article distributed under the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/).

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tharp, D.L., Bowles, D.K. KCa3.1 Inhibition Decreases Size and Alters Composition of Atherosclerotic Lesions Induced by Low, Oscillatory Flow. Artery Res 27, 93–100 (2021). https://doiorg.publicaciones.saludcastillayleon.es/10.2991/artres.k.210202.001

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.2991/artres.k.210202.001

Keywords

Artery Research

ISSN: 1876-4401

Contact us